skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Michael


21+ years of experience

Michael Hay - Pharmaintelligence
Michael Hay is the Head of Intelligence Products for Informa Pharma and Healthcare. His 16 years of financial markets experience have helped to shape our key products: Citeline, Datamonitor, BioMedTracker and Medtrack.
Michael has consulted for numerous top-tier pharmaceutical companies, and worked closely with top healthcare investment firms to provide insight on investment and trading decisions. He is the co-author of the Nature Biotechnology feature Clinical Development Success Rates for Investigational Drugs.

Michael came to Pharma Intelligence through the acquisition of Sagient in 2012, where he had been since 2004. Previously, he worked as a Manager in Thomson Financial’s Capital Markets Intelligence division.

Michael holds a BSc in Finance from the University of Colorado, Boulder (also his home town).

Analyst Articles